|
Original Artikel |
Datum |
Titel |
Autoren Alle Autoren |
1 |
[GO] |
2025―Mai―13 |
Gal-9: A potential game-changer in COVID-19 severity assessment |
Eduardo Davi Lima da Silva, Heloisa Isabela Leão, Ryan Cordeiro Silva, Nathália Tavares Ferreira, Amanda Pinheiro de Barros Albuquerque, André Machado de Siqueira, et al. (+4) Michelly Cristiny Pereira, Michelle Melgarejo da Rosa, Moacyr Jesus Barreto de Melo Rêgo, Maira Galdino da Rocha Pitta |
2 |
[GO] |
2025―Mrz―01 |
Serological responses to SARS-CoV-2 in vaccinated and unvaccinated individuals: a Canadian study |
Andrea Monjo, Tania Rodríguez-Ramos, Mark R. Bruder, Nguyen T.K. Vo, Mark Oremus, Kevin J. Stinson, et al. (+2) Brian Dixon, Marc G Aucoin |
3 |
[GO] |
2025―Feb―28 |
Expansion of SARS-CoV-2 mutations in patient with B-cell lymphoma and rare combination of ACE2, TLR4, DDX58 and IFIH1 variations: A retrospective analysis of the virus-host interplay |
Angelina Trifonova, Adelina Yosifova, Atanas Syarov, Andrey Velichkov, Martin Pasev, Svetlomir Takov, et al. (+4) Kalina Madarzhieva, Krassimir Angelov, Radoslava Vazharova, Velislava Terzieva |
4 |
[GO] |
2024―Nov―17 |
Long-term follow-up of anti-IFN-α2 autoantibody levels in hospitalized individuals with COVID-19 |
Maaike Cockx, Nick Geukens, Birthe Michiels, Doreen Dillaerts, Eveline Claeys, Olivia Vandekerckhove, et al. (+2) Natalie Lorent, Xavier Bossuyt |
5 |
[GO] |
2024―Mai―01 |
Post COVID-19 multisystem inflammatory syndrome in adults (MIS-A): Underappreciated in international health? A Case Series |
Marvyn T. Koning, Anouk Haine, Jesse Fens, Edske ter Bals, M. Cloos-van Balen, A. Faiz Karim |
6 |
[GO] |
2024―Feb―24 |
Case of Mitochondrial Encephalomyopathy Secondary to COVID-19 in a Pediatric Case of SIFD Syndrome with a Novel TRNT1 Mutation |
Amer Khojah, Lauren Gunderman, Ameera Bukhari, Aisha Mirza, Madeline Schutt, Aisha Ahmed |
7 |
[GO] |
2024―Jan―28 |
Evaluating Length of Immune Response to SARS-CoV2 Vaccine: A Cohort Review of Spike Protein Antibody Titer after Vaccination |
Zein Kattih, Jonathan Moore, Dimitre Stefanov, Priyanka Makkar, Viera Lakticova |
8 |
[GO] |
2023―Aug―23 |
Time-series COVID-19 policy outcome analysis of the 50U.S. states |
Yoshiyasu Takefuji, Junya Toyokura |
9 |
[GO] |
2023―Jul―20 |
Cross-protective Immunity Induced by Omicron Variant of SARS-CoV-2 |
Selia Chowdhury, Md. Shahraj Chowdhury, Nurjahan Shipa Chowdhury, Samia Chowdhury, Shajeda Chowdhury |
10 |
[GO] |
2023―Jun―10 |
Considerations on COVID-19 Vaccination |
Antonio La Cava |
11 |
[GO] |
2023―Apr―14 |
Erratum to “A case of de novo seronegative inflammatory oligoarthritis associated with COVID-19 infection” Clinical Immunology Communications 2 (2022) 159-161/ |
Lily H. Sung, Natalya Surmachevska, Jose E. Rubio |
12 |
[GO] |
2023―Feb―20 |
Lower NK Cell Numbers in Children with Untreated Juvenile Dermatomyositis During the COVID-19 Pandemic |
Christopher Costin, Gabrielle Morgan, Amer Khojah, Marisa Klein-Gitelman, Lauren M. Pachman |
13 |
[GO] |
2023―Feb―11 |
Predictors of mortality in patients with COVID-19 by flow cytometry |
Marco Bonilla Izquierdo, Ana María Navas Romo, Aurora Gema Sicilia Zafra, Juan de Dios López-González Garrido |
14 |
[GO] |
2023―Feb―04 |
Analysis of humoral and cellular immunity after SARS-CoV-2 vaccination in patients with multiple sclerosis treated with immunomodulatory drugs |
Virginia Meca-Lallana, Laura Esparcia-Pinedo, Clara Aguirre, Carolina Díaz-Pérez, Ainhoa Gutierrez-Cobos, Mónica Sobrado, et al. (+7) Estefanía Carabajal, Beatriz del Río, Noelia Ropero, Ramón Villagrasa, José Vivancos, Francisco Sanchez-Madrid, Arantzazu Alfranca |
15 |
[GO] |
2022―Dez―11 |
Partial recovery of SARS-CoV-2 immunity after booster vaccination in renal transplant recipients |
J.M. Urra, P. Castro, N. Jiménez, E. Moral, C. Vozmediano |
16 |
[GO] |
2022―Dez―01 |
Differential peripheral blood mononuclear cell reactivity against SARS-CoV-2 proteins in naïve and previously infected subjects following COVID-19 vaccination |
Elizabete Cristina Iseke Bispo, Amandda Évelin Silva-Carvalho, Marielly Reis Resende Sousa, Francisco de Assis Rocha Neves, Juliana Lott de Carvalho, Enrique Roberto Arganaraz, Felipe Saldanha-Araujo |
17 |
[GO] |
2022―Nov―17 |
Myocarditis following Coronavirus vaccination |
Khouloud Ferchichi, Imen Aouinti, Ahmed Zaiem, Ghozlane Lakhoua, Widd Kaabi, Ons Charfi, et al. (+3) Sarrah Kastalli, Riadh Daghfous, Sihem El Aidli |
18 |
[GO] |
2022―Okt―19 |
A case of de novo seronegative inflammatory oligoarthritis associated with COVID-19 infection |
Lily H. Sung, Natalya Surmachevska, Jose E. Rubio |
19 |
[GO] |
2022―Sep―29 |
Memory T cell responses in seronegative older adults following SARS-CoV-2 vaccination |
Merve Hafızoğlu, Arzu Okyar Bas, Ece Tavukçuoğlu, Zeynep Sahiner, Merve Güner Oytun, Sıla Ulutürk, et al. (+8) Hamdullah Yanık, Burcu Balam Doğu, Mustafa Cankurtaran, Güneş Esendağlı, Filiz Akbıyık, Banu Çakır, Serhat Ünal, Meltem Gülhan Halil |
20 |
[GO] |
2022―Sep―14 |
SARS-CoV-2 antibody determination in a vaccinated and recovered cohort in Austria |
Elisabeth Mara, Tobias Mader, Johannes Gratzer, Stefanie Hochegger, Thomas Pekar |
21 |
[GO] |
2022―Aug―27 |
Endogenous antibody response to SARS-CoV-2 in patients who received monoclonal antibodies against COVID-19: a systematic review |
Andrea Lombardi, Cecilia Azzarà, Giulia Renisi, Giulia Viero, Andrea Gori, Alessandra Bandera |
22 |
[GO] |
2022―Mai―14 |
COVID-19 Vaccine Safety and Adverse Event Analysis from Pakistan |
Syed Shahzad Hasan, Abdur Rashid, Sundus Osama, Zia Ul Mustafa, Hamid A. Merchant |
23 |
[GO] |
2022―Mai―05 |
C1 esterase inhibitor-mediated immunosuppression in COVID-19: friend or foe? |
Melissa A. Hausburg, Jason S. Williams, Kaysie L. Banton, Charles W. Mains, Michael Roshon, David Bar-Or |
24 |
[GO] |
2022―Mrz―10 |
Pharmacokinetics of Convalescent Plasma Therapy in a COVID-19 Patient with X-Linked Agammagobulinemia |
Jennifer L. Yates, David S. Palat, M. Kristina Subik, William T. Lee, Kathleen A. McDonough, Edward Conuel |
25 |
[GO] |
2022―Mrz―10 |
APPRAISING SARS-CoV-2 INFECTIONS AFTER FULL mRNA COVID-19 VACCINATION IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) |
Anderson Anuforo, Michael Sandhu, Jianghong Yu, Andras Perl |
26 |
[GO] |
2021―Dez―23 |
Altered pre-existing SARS-CoV-2-specific T cell responses in elderly individuals |
Naoyuki Taira, Sakura Toguchi, Mio Miyagi, Tomoari Mori, Hiroaki Tomori, Koichi Oshiro, et al. (+6) Osamu Tamai, Mitsuo Kina, Masatake Miyagi, Kentaro Tamaki, Mary K Collins, Hiroki Ishikawa |
27 |
[GO] |
2021―Okt―13 |
COVID-19 in a patient with Good's syndrome and in 13 patients with common variable immunodeficiency |
Hannes Lindahl, C I Edvard Smith, Peter Bergman |
28 |
[GO] |
2021―Okt―13 |
The “original antigenic sin” and its relevance for SARS-CoV-2 (COVID-19) vaccination. |
Ger T. Rijkers, Frans J. van Overveld |
29 |
[GO] |
2021―Okt―13 |
Prevalence of asymptomatic SARS-CoV-2 infection in an Austrian cohort |
Elisabeth Mara, Verena Breitsching, Tanja Schuster, Thomas Pekar |
30 |
[GO] |
2021―Sep―27 |
Pfizer-biontech COVID-19 RNA vaccination induces phosphatidylserine autoantibodies, cryoglobulinemia, and digital necrosis in a patient with pre-existing autoimmunity |
Sandy Nasr, Sara Khalil, Bernard J. Poiesz, Katalin Banki, Andras Perl |